{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06218875",
            "orgStudyIdInfo": {
                "id": "TGR 23-02AA"
            },
            "organization": {
                "fullName": "W.L.Gore & Associates",
                "class": "INDUSTRY"
            },
            "briefTitle": "Endovascular AAA Intervention Using the GORE\u00ae EXCLUDER\u00ae Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis",
            "officialTitle": "Assessment of Long Term, Endovascular AAA Intervention Using the GORE\u00ae EXCLUDER\u00ae Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "endovascular-aaa-intervention-using-the-gore-excluder-conformable-aaa-endoprosthesis-or-iliac-branch-endoprosthesis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2042-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2042-09-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-11",
            "studyFirstSubmitQcDate": "2024-01-11",
            "studyFirstPostDateStruct": {
                "date": "2024-01-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-13",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "W.L.Gore & Associates",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "A prospective, observational post-market registry collecting outcomes through a 10-year post procedure follow-up for patients treated with the GORE\u00ae EXCLUDER\u00ae Conformable AAA Endoprosthesis (EXCC Device) or the GORE\u00ae EXCLUDER\u00ae Iliac Branch Endoprosthesis (IBE Device) as a part of routine clinical practice.",
            "detailedDescription": "The purpose of the Gore Together Aortic Registry is to collect real-world data (RWD) for Gore aortic endovascular devices. Due to the nature of the program, patient selection, diagnostic imaging, and treatment interventions will be determined by physicians based on standard clinical practice. Therefore, the Sponsor will not be outlining requirements that would influence healthcare decisions.\n\nParticipants will be asked to return for regular scheduled visits as requested by their surgeon. Patients will report any issues they may have regarding the device or surgery to their surgeon/doctor."
        },
        "conditionsModule": {
            "conditions": [
                "AAA - Abdominal Aortic Aneurysm"
            ],
            "keywords": [
                "Aneurysm",
                "Aneurysm Repair",
                "Endovascular",
                "EVAR",
                "Endoprosthesis",
                "Aortic",
                "Aortic Repair"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": true,
            "targetDuration": "10 Years",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 3500,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "GORE\u00ae EXCLUDER\u00ae Conformable AAA Endoprosthesis (EXCC Device)",
                    "description": "Patients treated with the EXCC Device"
                },
                {
                    "label": "GORE\u00ae EXCLUDER\u00ae Iliac Branch Endoprosthesis (IBE Device)",
                    "description": "Patients treated with the IBE Device"
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Deployment Technical Success",
                    "description": "Successful access, delivery, and accurate deployment of the device to the intended location, and retrieval of the delivery system.",
                    "timeFrame": "Time of Surgery"
                },
                {
                    "measure": "Lesion-related Mortality",
                    "description": "Death related to the index endovascular procedure, secondary procedure associated with the index lesion or the registry device, or any death where the treated disease / index lesion or registry device caused or significantly contributed to the death",
                    "timeFrame": "Day 30 through Year 10"
                },
                {
                    "measure": "Lesion Rupture",
                    "description": "Rupture in the treated segment of the vessel (e.g., aorta or branch) verified with direct observation or Computed Tomographic Angiography (CTA) scan",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "Lesion Enlargement",
                    "description": "An increase in maximum vessel (e.g., aorta or treated branch) diameter of \\> 5 mm in the region encompassed by the initial lesion as compared to baseline using orthogonal (i.e., perpendicular to the centerline) measurements on CTA scans",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "Endoleaks",
                    "description": "Perfusion of a treated lesion identified through imaging analysis",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "Device Migration",
                    "description": "Longitudinal movement of all or part of the device for a distance \u2265 10 mm, as confirmed by CTA scan, relative to anatomical landmarks and device positioning at the first post-operative CTA scan.",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "Loss of aortic / branch patency",
                    "description": "No flow or contrast detected through the implanted aortic and/or branch component (for branched devices) confirmed with imaging and/or direct observation.",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "New onset renal failure",
                    "description": "New onset sustained renal failure identified within 30 days of the index endovascular procedure, combined with requiring dialysis for \\> 4 weeks",
                    "timeFrame": "Time of Surgery through Day 30"
                },
                {
                    "measure": "Renal function deterioration",
                    "description": "New onset of a decrease in eGFR \\> 30% following treatment when compared to baseline eGFR.",
                    "timeFrame": "Time of Surgery through Day 30"
                },
                {
                    "measure": "Device integrity events",
                    "description": "wire fractures, stent kinking, disruption/tears in the graft component, or stent compression or invagination identified through imaging analysis",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "Reintervention",
                    "description": "Additional surgical or interventional procedure related to the treated disease / index lesion, the registry device, or to the treatment / procedure.",
                    "timeFrame": "Time of Surgery through Year 10"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Characterization of remote data collection to supplement follow-up activities",
                    "description": "An exploratory description intended to assign significance to an increasingly used method of participant engagement to assess utilization, frequency by time, outcomes, contribution to total follow-up, need for elevation of care",
                    "timeFrame": "Time of Surgery through Year 10"
                },
                {
                    "measure": "New onset buttock claudication / erectile dysfunction",
                    "description": "Patient reported",
                    "timeFrame": "Time of Surgery through Year 1"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements\n2. Patient has been or is intended to be treated with an eligible registry device\n3. Patient is age \u2265 18 years at time of informed consent signature.\n\nExclusion Criteria:\n\n1. Patient who is, at the time of consent, unlikely to be available for standard of care (SOC) follow-up visits as defined by the site's guidelines and procedures.\n2. Patient with exclusion criteria required by local law.\n3. Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study within 12 months of Together Registry enrollment. Subjects cannot be enrolled in another Together Registry module protocol.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Registry participants are derived from patients presenting with vascular disease that may benefit from the placement of an endovascular stent graft. The target registry population is patients who are treated with either EXCC or IBE Device at participating sites. This includes initial procedures and reinterventions (regardless of original intervention). Only patients who meet all the inclusion and none of the exclusion criteria will be included in the registry.\n\nThe registry has been designed with broad eligibility criteria to optimize the visibility of overall registry device use. An integral requirement to the target subject population is that the decision to use a GORE\u00ae EXCLUDER\u00ae product has been made prior to considering the patient for possible registry participation.",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "K Martin",
                    "role": "CONTACT",
                    "phone": "928-864-2223",
                    "email": "kgmartin@wlgore.com"
                },
                {
                    "name": "A Hoedt",
                    "role": "CONTACT",
                    "phone": "928-963-4445"
                }
            ],
            "overallOfficials": [
                {
                    "name": "S. Han",
                    "affiliation": "University of Southern California",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mission Hospital",
                    "status": "RECRUITING",
                    "city": "Asheville",
                    "state": "North Carolina",
                    "zip": "28801",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lynne Hampton",
                            "role": "CONTACT",
                            "email": "Lynne.Hampton@HCAhealthcare.com"
                        },
                        {
                            "name": "John Henretta, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.60095,
                        "lon": -82.55402
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Data to be shared will be pseudo-anonymized with subject names and birthdates removed, but information such as procedure date will not.",
            "timeFrame": "Sharing of IPD will not routinely be performed and is contingent on an assessment of the researcher's proposal for novelty or value in advancing educational, quality or medical practice objectives in use of this data.",
            "accessCriteria": "See above"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000783",
                    "term": "Aneurysm"
                },
                {
                    "id": "D000001014",
                    "term": "Aortic Aneurysm"
                },
                {
                    "id": "D000017544",
                    "term": "Aortic Aneurysm, Abdominal"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000001018",
                    "term": "Aortic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4113",
                    "name": "Aneurysm",
                    "asFound": "Aneurysm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4330",
                    "name": "Aortic Aneurysm",
                    "asFound": "Aortic Aneurysm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19800",
                    "name": "Aortic Aneurysm, Abdominal",
                    "asFound": "AAA - Abdominal Aortic Aneurysm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4334",
                    "name": "Aortic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T66",
                    "name": "Abdominal Aortic Aneurysm",
                    "asFound": "Abdominal Aortic Aneurysm",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}